Superstring Capital Management LP Century Therapeutics, Inc. Transaction History

Superstring Capital Management LP

  • $115 Billion
  • Q4 2024

A detailed history of Superstring Capital Management LP transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Superstring Capital Management LP holds 462,963 shares of IPSC stock, worth $236,111. This represents 0.4% of its overall portfolio holdings.

Number of Shares
462,963
Holding current value
$236,111
% of portfolio
0.4%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$1.0 - $1.72 $462,963 - $796,296
462,963 New
462,963 $468 Million

About Century Therapeutics, Inc.

IPSC Quotes by TradingView
  • Ticker IPSC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,881,800
  • Market Cap $30M
  • Description
  • Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...
More about IPSC
Track This Portfolio

Track Superstring Capital Management LP Portfolio

Follow Superstring Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Superstring Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Superstring Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email